PH30083A - Treatment of lower urinary tract disorders - Google Patents

Treatment of lower urinary tract disorders

Info

Publication number: PH30083A
Authority: PH; Philippines
Prior art keywords: urinary tract; lower urinary; treatment; tract disorders; disorders
Prior art date: 1991-02-25

Application number

PH43958A

Other languages

English (en)

Inventor

Mark Mortensen Foreman

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-02-25

Filing date

1992-02-21

Publication date

1996-12-27

1992-02-21 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1996-12-27 Publication of PH30083A publication Critical patent/PH30083A/en

Links

208000026723 Urinary tract disease Diseases 0.000 title abstract 2
208000014001 urinary system disease Diseases 0.000 title abstract 2
VHGCDTVCOLNTBX-QGZVFWFLSA-N atomoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=CC=C1C VHGCDTVCOLNTBX-QGZVFWFLSA-N 0.000 abstract 1
229960002430 atomoxetine Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
- A61K31/025—Halogenated hydrocarbons carbocyclic
- A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)

PH43958A 1991-02-25 1992-02-21 Treatment of lower urinary tract disorders PH30083A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US66076791A	1991-02-25	1991-02-25

Publications (1)

Publication Number	Publication Date
PH30083A true PH30083A (en)	1996-12-27

Family

ID=24650885

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH43958A PH30083A (en)	1991-02-25	1992-02-21	Treatment of lower urinary tract disorders

Country Status (12)

Country	Link
US (1)	US5441985A (de)
EP (1)	EP0501705B1 (de)
JP (1)	JP3222524B2 (de)
KR (1)	KR920016088A (de)
AT (1)	ATE137965T1 (de)
AU (1)	AU642582B2 (de)
CA (1)	CA2061665C (de)
DE (1)	DE69210654T2 (de)
DK (1)	DK0501705T3 (de)
HU (1)	HU215122B (de)
PH (1)	PH30083A (de)
ZA (1)	ZA921292B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9202218D0 (sv) *	1992-07-22	1992-07-22	Kabi Pharmacia Ab	Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation
TW344661B (en) *	1993-11-24	1998-11-11	Lilly Co Eli	Pharmaceutical composition for treatment of incontinence
US6113876A (en) *	1996-01-29	2000-09-05	Eli Lilly And Company	Methods of increasing sphincter competence
UA57107C2 (uk)	1997-09-23	2003-06-16	Елі Ліллі Енд Компані	Спосіб лікування розладу поведінки
AUPP627498A0 (en) *	1998-10-02	1998-10-22	University Of Queensland, The	Novel peptides - i
DE60035232T2 (de) *	1999-07-01	2008-02-14	Pharmacia & Upjohn Co. Llc, Kalamazoo	(S,S)-Reboxetin zur Behandlung von chronischem Müdigkeits-Syndrom
JP4337201B2 (ja)	1999-12-27	2009-09-30	トヨタ紡織株式会社	スプリング構造体の取付構造
JP4348808B2 (ja)	1999-12-27	2009-10-21	トヨタ紡織株式会社	枠体に対する機能性部材の取付構造
TR200705146T1 (tr) *	2001-03-06	2008-02-21	Eli Lilly And Company	Monoamin Yükselmesinin Engellenmesi
EP1424079A1 (de) *	2002-11-27	2004-06-02	Boehringer Ingelheim International GmbH	Kombination eines beta-3-Rezeptoragonisten und eines Serotonin und/oder Norepinephrin-Wiederaufnahmeinhibitors
EP2412719A1 (de)	2002-12-02	2012-02-01	Xenome Ltd	Chi-Conotoxin-Peptide
ATE547424T1 (de)	2002-12-02	2012-03-15	Xenome Ltd	Chi-conotoxinpeptide mit einer n-terminalen pyroglutaminsäure
EP1539181B1 (de) *	2003-04-04	2007-06-27	Dynogen Pharmaceuticals Inc.	Methode zur behandlung von erkrankungen der unteren harnwege
WO2005065673A1 (en) *	2003-12-31	2005-07-21	Actavis Group Hf	Atomoxetine formulations
AP2006003771A0 (en) *	2004-04-30	2006-10-31	Warner Lambert Co	Substituted morpholine compounds for the treatmentof central nervous system disorders
GB0409744D0 (en) *	2004-04-30	2004-06-09	Pfizer Ltd	Novel compounds
US20060189698A1 (en) *	2005-02-24	2006-08-24	Check Jerome H	Treatment of interstitial cystitis
KR101220803B1 (ko)	2010-12-28	2013-01-11	주식회사 포스코	차량용 시트 구조
DE102013019618B4 (de) *	2013-11-25	2024-08-29	Avlen Georges	Tri- und Tetracyclische Verbindungen zur Behandlung von Inkontinenz

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4314081A (en) *	1974-01-10	1982-02-02	Eli Lilly And Company	Arloxyphenylpropylamines
FI77018C (fi) *	1980-11-14	1989-01-10	Lilly Co Eli	Analogifoerfarande foer framstaellning av antidepressivt aktiv (-)-enantiomer av n-metyl-n-/3-(2-metylfenoxi) -3-fenylpropyl/amin och dess farmaceutiskt godtagbara salt.
US4956388A (en) *	1986-12-22	1990-09-11	Eli Lilly And Company	3-aryloxy-3-substituted propanamines
CA1329937C (en) *	1987-04-09	1994-05-31	Dennis Charles Thompson	1-phenyl-3-naphthalenyloxypropanamines
SE8804003D0 (sv) *	1988-11-04	1988-11-04	Pharmacia Ab	Compounds for the treatment of urinary incontinence

1992
- 1992-02-21 AU AU11170/92A patent/AU642582B2/en not_active Ceased
- 1992-02-21 ZA ZA921292A patent/ZA921292B/xx unknown
- 1992-02-21 CA CA002061665A patent/CA2061665C/en not_active Expired - Fee Related
- 1992-02-21 PH PH43958A patent/PH30083A/en unknown
- 1992-02-22 KR KR1019920002706A patent/KR920016088A/ko not_active Ceased
- 1992-02-24 AT AT92301494T patent/ATE137965T1/de not_active IP Right Cessation
- 1992-02-24 DE DE69210654T patent/DE69210654T2/de not_active Expired - Fee Related
- 1992-02-24 JP JP03602992A patent/JP3222524B2/ja not_active Expired - Fee Related
- 1992-02-24 DK DK92301494.8T patent/DK0501705T3/da active
- 1992-02-24 EP EP92301494A patent/EP0501705B1/de not_active Expired - Lifetime
- 1992-02-24 HU HU9200602A patent/HU215122B/hu not_active IP Right Cessation
1993
- 1993-05-13 US US08/061,335 patent/US5441985A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0501705A1 (de)	1992-09-02
DE69210654T2 (de)	1996-10-24
HU215122B (hu)	1998-09-28
DK0501705T3 (da)	1996-06-03
KR920016088A (ko)	1992-09-24
JPH0570343A (ja)	1993-03-23
HU9200602D0 (en)	1992-05-28
AU642582B2 (en)	1993-10-21
ATE137965T1 (de)	1996-06-15
AU1117092A (en)	1992-08-27
US5441985A (en)	1995-08-15
CA2061665C (en)	2002-04-16
HUT62192A (en)	1993-04-28
EP0501705B1 (de)	1996-05-15
CA2061665A1 (en)	1992-08-26
DE69210654D1 (de)	1996-06-20
ZA921292B (en)	1993-08-23
JP3222524B2 (ja)	2001-10-29

Similar Documents

Publication	Publication Date	Title
ZA921292B (en)	1993-08-23	Treatment of lower urinary tract disorders.
EP0509317A3 (en)	1993-03-03	Use of droloxifene in the treatment of bone diseases
NZ334124A (en)	2000-10-27	Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
EP1029540A3 (de)	2001-05-16	Verwendung von Droloxifen zur Behandlung von cardiovaskulären Erkrankungen
PL299814A1 (en)	1994-02-07	Pharmaceutical preparation inhibiting depletion of human bone tissue
EP0550006A3 (en)	1994-11-23	Use of n-acyl derivatives of aminoalcohols for the manufacture of a medicament for the treatment of pathologies involving mast cells
NO994165L (no)	1999-10-25	Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
HU9203288D0 (en)	1992-12-28	Method for producing a compound of medical effect
EP0279887A3 (en)	1990-08-22	Carnitine directed pharmaceutical agents and their use for the manufacture of a medicament for the treatment of muscle disorder
KR100213963B1 (en)	1999-08-02	Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis
EP0437929A3 (en)	1991-09-25	Use of diadenosine-5',5'''-p1,p4-tetraphosphate for the manufacture of a medicament for the treatment of heart disease
EP0448004A3 (en)	1991-12-04	Catheter for medical treatment
CA2260863A1 (en)	1998-02-12	Treatment of psychotic disorders
NZ303993A (en)	2000-12-22	Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders
AU4476089A (en)	1990-05-24	Use of azepinone derivatives for the treatment of respiratory tract disorders
DE69100171D1 (de)	1993-08-19	Synergistische kombination zur ophthalmischen verwendung.
GR3022706T3 (en)	1997-05-31	Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
WO1986006960A3 (en)	1987-01-29	Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
EP0666745A4 (de)	1995-10-25	Diagnose und therapie der parkinson-krankheit.
ZA924128B (en)	1993-03-25	New combination preparations for treatment of Parkinson's disease.
UA29461C2 (uk)	2000-11-15	Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
EP0642338A1 (de)	1995-03-15	Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit.
EP0408525A3 (en)	1992-03-04	Use in therapy of 10-amino-5,6-dihydro-11h-dibenzo(b,e)azepine-6,11-dione and derivatives as drugs for use in the treatment of urinary incontinence
GR3037039T3 (en)	2002-01-31	Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants.
IL117465A (en)	2000-07-26	Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis